This enduring education aims to help primary care clinicians recognize type 2 inflammatory diseases, understand the burden associated with these diseases, and provide patient-centered management of these diseases. As a result of this educational curriculum, learners should be better able to: 1. Describe how type 2 inflammation contributes to the pathophysiology of chronic type 2 inflammatory diseases; 2. Explain the rationale for prompt recognition of patients with multiple type 2 inflammatory comorbidities; 3. Discuss treatment considerations for patients with multiple type 2 inflammatory diseases; and, 4. Outline strategies for maximizing patient engagement and empowerment to improve outcomes in type 2 inflammatory diseases
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/FHX
- Start Date: 2025-04-30 05:00:00
- End Date: 2025-04-30 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 136971.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all